findmyKOL
Clinical trialNCT00099645CompletedPhase 1/PHASE2Interventional

Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment48HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the anti-HIV activity and safety of 3 different doses of mifepristone (also known as VGX-410 and RU486) in HIV infected people. Hypothesis: Mifepristone will be generally safe (no serious adverse effects) and well tolerated.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Harbor-Ucla Med. Ctr. Crs

    Torrance, California, United States

  • Georgetown University Crs (gu Crs)

    Washington D.C., District of Columbia, United States

  • University of Minnesota, Actu

    Minneapolis, Minnesota, United States

  • Washington U Crs

    St Louis, Missouri, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • the Ohio State Univ. Aids Crs

    Columbus, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • Univ. of Pennsylvania Health System, Presbyterian Med. Ctr.

    Philadelphia, Pennsylvania, United States

  • Pitt Crs

    Pittsburgh, Pennsylvania, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 Aug 2005
Last update posted
1 Nov 2021
Registered enrollment
48
Registry id
NCT00099645

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.